Orthopediatrics Corp Cash Flow Conversion Efficiency
Orthopediatrics Corp cash flow conversion efficiency. Based on the latest financial reports, Orthopediatrics Corp (KIDS) has a cash flow conversion efficiency ratio of 0.003x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($928.00K) by net assets ($343.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Orthopediatrics Corp (2014–2025)
Cash flow conversion efficiency of Orthopediatrics Corp from 2014 to 2025. This chart illustrates how Orthopediatrics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Orthopediatrics Corp stock price today for real-time trading data and today's change.
Orthopediatrics Corp Cash Flow Conversion Ratio Explained
Orthopediatrics Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Orthopediatrics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orthopediatrics Corp ranked by their cash flow conversion efficiency. Also see Orthopediatrics Corp market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elec-Tech International Co Ltd
SHE:002005
|
-0.170x |
|
Ningbo Marine Co Ltd
SHG:600798
|
0.040x |
|
Baotek Industrial Materials Ltd
TWO:5340
|
0.033x |
|
Zhejiang Netsun Co Ltd
SHE:002095
|
0.015x |
|
Onterris
NYSE:ONT
|
0.014x |
|
NETGEAR Inc
NASDAQ:NTGR
|
-0.019x |
|
SENORES PHARMACEUTICALS L
NSE:SENORES
|
0.025x |
|
Rio2 Ltd
V:RIO
|
-0.051x |
Annual Cash Flow Conversion Efficiency for Orthopediatrics Corp (2014–2025)
The table below shows the annual cash flow conversion efficiency of Orthopediatrics Corp from 2014 to 2025. Review free cash flow generation of Orthopediatrics Corp to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $346.60 Million | $-4.85 Million | -0.014x | +81.65% |
| 2024-12-31 | $354.57 Million | $-27.05 Million | -0.076x | -6.34% |
| 2023-12-31 | $377.02 Million | $-27.05 Million | -0.072x | -24.79% |
| 2022-12-31 | $378.65 Million | $-21.77 Million | -0.057x | +0.83% |
| 2021-12-31 | $225.37 Million | $-13.06 Million | -0.058x | +26.56% |
| 2020-12-31 | $234.77 Million | $-18.53 Million | -0.079x | +36.76% |
| 2019-12-31 | $142.36 Million | $-17.77 Million | -0.125x | +34.53% |
| 2018-12-31 | $81.73 Million | $-15.58 Million | -0.191x | -25.47% |
| 2017-12-31 | $47.49 Million | $-7.22 Million | -0.152x | +18.61% |
| 2016-12-31 | $5.99 Million | $-1.12 Million | -0.187x | -136.81% |
| 2015-12-31 | $11.31 Million | $-892.00K | -0.079x | +85.72% |
| 2014-12-31 | $17.98 Million | $-9.92 Million | -0.552x | -- |
About Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sp… Read more